|
2014
|
Invention
|
Use of cysteamine and derivatives thereof to treat mitochondrial diseases. The present disclosure... |
|
|
Invention
|
Methods for analyzing cysteamine compositions. Methods of analyzing purity of compositions compri... |
|
|
Invention
|
Delayed release cysteamine bead formulation. An enteric-coated bead dosage form of cysteamine, an... |
|
2008
|
Invention
|
Cyclic receptor-associated protein (rap) peptides. The present invention relates generally to rec... |
|
2007
|
Invention
|
Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates. T... |
|
2006
|
Invention
|
Compositions comprising receptor-associated protein (rap) variants specific for cr-containing pro... |
|
|
Invention
|
Compositions comprising receptor - associated protein (rap) variants specific for lrp2 and uses t... |
|
2004
|
Invention
|
Delivery of therapeutic compounds to the brain and other tissues. The present invention is direct... |
|
2002
|
Invention
|
Compositions and methods for modulating blood-brain barrier transport. This invention provides co... |
